NYSE - Delayed Quote • USD
Thermo Fisher Scientific Inc. (TMO)
At close: April 22 at 4:00 PM EDT
Pre-Market: 7:20 AM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 20 | 19 | 26 | 26 |
| Avg. Estimate | 4.71 | 5.12 | 21.55 | 24.07 |
| Low Estimate | 4.61 | 4.99 | 21.34 | 22.25 |
| High Estimate | 4.75 | 5.36 | 21.9 | 25.14 |
| Year Ago EPS | 5.03 | 5.15 | 21.55 | 21.55 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 18 | 18 | 25 | 25 |
| Avg. Estimate | 10.17B | 10.49B | 42.84B | 45.93B |
| Low Estimate | 10.09B | 10.22B | 42.35B | 45.16B |
| High Estimate | 10.43B | 10.78B | 43.26B | 46.96B |
| Year Ago Sales | 10.71B | 10.98B | 42.86B | 42.84B |
| Sales Growth (year/est) | -5.00% | -4.50% | -0.00% | 7.20% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 5.03 | 5.42 | 5.61 | 5.64 |
| EPS Actual | 5.03 | 5.15 | 5.69 | 5.67 |
| Difference | 0 | -0.27 | 0.08 | 0.03 |
| Surprise % | 0.00% | -5.00% | 1.40% | 0.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 4.71 | 5.12 | 21.55 | 24.07 |
| 7 Days Ago | 4.71 | 5.13 | 21.56 | 24.08 |
| 30 Days Ago | 4.73 | 5.13 | 21.58 | 24.15 |
| 60 Days Ago | 4.73 | 5.14 | 21.56 | 24.15 |
| 90 Days Ago | 4.99 | 5.22 | 22.04 | 24.73 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | 3 | 1 | 4 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 2 | 2 | 4 | 4 |
Growth Estimates
| CURRENCY IN USD | TMO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -6.40% | -- | -- | 0.20% |
| Next Qtr. | -0.60% | -- | -- | 9.40% |
| Current Year | 0.00% | -- | -- | 4.40% |
| Next Year | 11.70% | -- | -- | 13.40% |
| Next 5 Years (per annum) | 6.71% | -- | -- | 11.07% |
| Past 5 Years (per annum) | 15.00% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | HSBC: Buy to Buy | 4/17/2024 |
| Maintains | Goldman Sachs: Buy to Buy | 4/10/2024 |
| Maintains | Evercore ISI Group: Outperform to Outperform | 4/4/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 2/1/2024 |
| Maintains | Raymond James: Outperform to Outperform | 2/1/2024 |
| Downgrade | Barclays: Overweight to Equal-Weight | 1/24/2024 |
Related Tickers
DHR Danaher Corporation
236.08
+0.24%
IDXX IDEXX Laboratories, Inc.
479.57
+0.68%
ILMN Illumina, Inc.
120.25
+2.40%
A Agilent Technologies, Inc.
133.91
+0.89%
MEDP Medpace Holdings, Inc.
376.26
+1.15%
WAT Waters Corporation
299.23
+1.06%
MTD Mettler-Toledo International Inc.
1,199.46
+0.92%
IQV IQVIA Holdings Inc.
231.34
+1.42%
EXAS Exact Sciences Corporation
62.41
+2.38%
CRL Charles River Laboratories International, Inc.
232.56
+2.55%